ARIEL ALONSO / THEOPHILE BIGIRUMURAME / TOMASZ BURZYKOWSKI / MARC BUYSE / GEERT MOLENBERGHS / LEACKY MUCH
An important factor that affects the duration, complexity and cost of a clinical trial is the endpoint used to study the treatment’s efficacy. When a true endpoint is difficult to use because of such factors as long follow-up times or prohibitive cost, it is sometimes possible to use a surrogate endpoint that can be measured in a more convenient or cost-effective way. This book focuses on the use of surrogate endpoint evaluation methods in practice, using SAS and R.
